Biography
Paul is a Health Economist who helps the health care sector, governments, research institutions and non-government organisations make better decisions when it comes to investing money in health care services and the prevention of disease. He achieves this through extensive experience with various economic evaluation techniques, such as decision analytic modelling, dynamic simulation modelling and within-trial economic analysis. These approaches are supported by applying scientific evidence synthesis techniques founded on evidence-based medicine, such as systematic reviews, meta-analysis, health technology assessment and formal clinical guideline development methods. Paul has developed these skills and experience by working at various governments and academic institutions, including the National Institute for Health and Care Excellence (NICE) in the UK, Queensland Health and now Deakin University. He has presented at various conferences on several continents, provided introductory seminars on health economics, and teaches and supervises postgraduate students.
Read more on Paul's profileKnowledge areas
- Economic evaluation of healthcare programmes
- Decision analytic modelling and economic modelling
- Systematic reviewing and meta-analysis
- Data analysis
- Clinical guideline development
- Health technology assessment
- Prevention of chronic disease
- Cardiovascular disease
- Hearing
- Telehealth
Professional activities
Member of:
- Economics of Obesity Special Interest Group, International Health Economics Association
- Australian Health Economics Society
Projects
Economics of Prevention
- Cost-effectiveness analysis of the Victorian Quitline service (a new economic model for tobacco cessation interventions including microsimulation and productivity measures)
- Value of alcohol use prevention (broad systematic review of the health and economic burden of alcohol use in Australia and evidence on the effectiveness and cost-effectiveness of interventions to reduce this harm)
- Value of Prevention (broad literature review of the health and economic burden of smoking, diet, physical inactivity and obesity and the evidence on interventions to reduce this harm)
- Compelling Case for Prevention (system dynamics model with 6 risk factors and 18 diseases to analyse the health, financial and productivity impacts of reducing risk factor prevalence)
- The health burden of preventable disease in Australia
- The economic burden of preventable disease in Australia
Economics of Hearing
Economics of Cardiovascular Disease
Past projects
At the National Institute for Health and Care Excellence (NICE) in London, Paul led the economic modelling and systematic review of economic evidence for the following clinical guidelines;
- Strategies for the identification and diagnosis of familial hypercholesterolaemia (Familial hypercholesterolaemia: identification and management)
- Active warming methods for the prevention of inadvertent perioperative hypothermia (Hypothermia: prevention and management in adults having surgery)
- Strategies for diagnosing coronary artery disease in people with stable chest pain (Chest pain of recent onset: assessment and diagnosis)
- Medicines for the prophylaxis of chronic migraine (Headaches in over 12s: diagnosis and management)
Paul was also Health Economics Lead, responsible for the quality assurance of externally developed guidelines, or led the systematic reviews of economic evidence, for over 20 other clinical guidelines not listed here.
Publications
N Patel, A Malicka, S McGinnity, R Anderson, A Paolini, P Crosland
(2022), Vol. 43, pp. 507-518, Ear and Hearing, Philadelphia, Pa., C1
K Galvin, C Sucher, R Bennett, A Ebrahimi-Madiseh, P Crosland, R Eikelboom
(2022), International Journal of Audiology, C1
P Nguyen, J Ananthapavan, E Tan, P Crosland, S Bowe, L Gao, D Dunstan, M Moodie
(2022), Vol. 19, International Journal of Behavioral Nutrition and Physical Activity, C1
E Howse, M Crane, I Hanigan, L Gunn, P Crosland, D Ding, M Hensher, L Rychetnik
(2021), Vol. 16, pp. 1-11, Environmental Research Letters, Bristol, Eng., C1
S Cornell, K Pickles, P Crosland, C de Wet, L Trevena, C Bonner
(2021), pp. 1-11, Health Promotion Journal of Australia, Hoboken NJ, C1
The health burden of preventable disease in Australia: a systematic review
Paul Crosland, Jaithri Ananthapavan, Jacqueline Davison, Michael Lambert, Rob Carter
(2019), Vol. 43, pp. 163-170, Australian and New Zealand journal of public health, Chichester, Eng., C1
The economic cost of preventable disease in Australia: a systematic review of estimates and methods
P Crosland, J Ananthapavan, J Davison, M Lambert, R Carter
(2019), Vol. 43, pp. 484-495, Australian and New Zealand journal of public health, Chichester, Eng., C1
Paul Crosland, Ross Maconachie, Sara Buckner, Hugh McGuire, Steve Humphries, Nadeem Qureshi
(2018), Vol. 275, pp. 80-87, Atherosclerosis, Amsterdam, The Netherlands, C1
K Hopkins, P Crosland, N Elliott, S Bewley, Clinical Guidelines Update Committee B
(2016), Vol. 50, pp. 184-186, British journal of sports medicine, London, Eng., C1-1
Hypothermia: prevention and management in adults having surgery
P Crosland
(2016), London, Eng., A6-1
J Whitty, C Tallis, K-H Nguyen, P Scuffham, P Crosland, K Hewson, R Pai Mangalore, M Black, G Holtmann
(2014), Vol. 17, pp. 159-165, journal of medical economics, Abingdon, Eng., C1-1
J Whitty, P Crosland, K Hewson, R Narula, T Nathan, P Campbell, A Keller, P Scuffham
(2014), Vol. 113, pp. 21-28, BJU international, Chichester, Eng., C1-1
Funded Projects at Deakin
Other Public Sector Funding
Integration of pharmacy services across the Barwon Southwest region.
A/Prof Kevin Mc Namara, Mr Paul Crosland, Dr Kate Kloot, Dr Andrea Hernan, Mrs Hannah Beks, Prof Vincent Versace
- 2018: $40,000
Economic impact of liquor licensing in NSW.
Mr Paul Crosland
- 2022: $40,000
Industry and Other Funding
Compelling Case for Prevention Project; TAPPC (The Australian Prevention Partnership Centre)
Mr Paul Crosland, Emeritus Professor Rob Carter
- 2021: $14,000
- 2020: $123,266
- 2019: $160,000
- 2018: $80,000
Evidence Check: Value of Primary Prevention of Alcohol Consumption.
Mr Paul Crosland
- 2021: $42,000
Supervisions
No completed student supervisions to report